SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gufic Biosciences informs about outcome of board meeting

11 Oct 2023 Evaluate
Gufic Biosciences has informed that in furtherance to the intimation dated September 1, 2023 in respect of issue of 33,33,000 equity shares to Non?Promoter through Preferential Issue and for which the Company has sought the approval of the shareholders at the 39th Annual General Meeting held on September 29, 2023 and In?principle approval from Stock Exchanges on September 26, 2023 and September 27, 2023 respectively. Also informed that, upon receipt of share application money from the eligible allottee, the Board of Directors of the Company at its Meeting held today, Wednesday, October 11, 2023, considered and approved the allotment of 33,33,000 (Thirty Three Lakhs Thirty Three Thousand) fully paid up equity shares of the face value of Re 1 each (Equity Shares) to Motilal Oswal Financial Services, on a preferential basis (Preferential Issue) in accordance with the provisions of the Chapter V of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, (SEBI ICDR Regulations) and Companies Act, 2013, as amended from time to time, and other applicable laws in force, at a price of Rs 300 (including premium of Rs 299 per Equity share) for an amount aggregating to Rs 99,99,00,000 (Rupees Ninety?Nine Crores Ninety?Nine Lakhs only).

The above information is a part of company’s filings submitted to BSE.

Gufic Biosciences Share Price

301.30 -1.35 (-0.45%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×